Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media
Authors
Keywords
-
Journal
mAbs
Volume 10, Issue 3, Pages 488-499
Publisher
Informa UK Limited
Online
2018-02-01
DOI
10.1080/19420862.2018.1433978
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A semi-empirical glycosylation model of a camelid monoclonal antibody under hypothermia cell culture conditions
- (2017) Hengameh Aghamohseni et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Manufacturing history of etanercept (Enbrel®): Consistency of product quality through major process revisions
- (2017) Brian Hassett et al. mAbs
- Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve
- (2017) Cristina Scavone et al. PHARMACOLOGICAL RESEARCH
- Improving lactate metabolism in an intensified CHO culture process: productivity and product quality considerations
- (2016) Sen Xu et al. BIOPROCESS AND BIOSYSTEMS ENGINEERING
- FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality
- (2016) Salina Louie et al. BIOTECHNOLOGY AND BIOENGINEERING
- GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes
- (2016) Oliver von Richter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies
- (2016) Sha Sha et al. TRENDS IN BIOTECHNOLOGY
- When Good Intentions Go Awry: Modification of a Recombinant Monoclonal Antibody in Chemically Defined Cell Culture by Xylosone, an Oxidative Product of Ascorbic Acid
- (2015) Chris Chumsae et al. ANALYTICAL CHEMISTRY
- A robust method for increasing Fc glycan high mannose level of recombinant antibodies
- (2015) Chung-Jr Huang et al. BIOTECHNOLOGY AND BIOENGINEERING
- Cell culture media supplementation of bioflavonoids for the targeted reduction of acidic species charge variants on recombinant therapeutic proteins
- (2015) Patrick Hossler et al. BIOTECHNOLOGY PROGRESS
- Effect of temperature shift on levels of acidic charge variants in IgG monoclonal antibodies in Chinese hamster ovary cell culture
- (2015) Shohei Kishishita et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Investigation of Color in a Fusion Protein Using Advanced Analytical Techniques: Delineating Contributions from Oxidation Products and Process Related Impurities
- (2015) Hangtian Song et al. PHARMACEUTICAL RESEARCH
- Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest
- (2014) Gayle E Derfus et al. mAbs
- Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge
- (2014) Bing Li et al. mAbs
- Biopharmaceutical benchmarks 2014
- (2014) Gary Walsh NATURE BIOTECHNOLOGY
- Effect of cell culture medium components on color of formulated monoclonal antibody drug substance
- (2013) Natarajan Vijayasankaran et al. BIOTECHNOLOGY PROGRESS
- Hydroxocobalamin association during cell culture results in pink therapeutic proteins
- (2013) Kenneth M Prentice et al. mAbs
- Brown drug substance color investigation in cell culture manufacturing using chemically defined media: A case study
- (2013) Jianlin Xu et al. PROCESS BIOCHEMISTRY
- CHO Quasispecies—Implications for Manufacturing Processes
- (2013) Florian Wurm Processes
- Effects of high passage cultivation on CHO cells: a global analysis
- (2012) T. F. Beckmann et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Characterization of the basic charge variants of a human IgG1
- (2012) Timothy Kaschak et al. mAbs
- Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
- (2012) Yi Du et al. mAbs
- Effect of process change from perfusion to fed-batch on product comparability for biosimilar monoclonal antibody
- (2012) Soo-Young Lee et al. PROCESS BIOCHEMISTRY
- Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process
- (2011) Jun Luo et al. BIOTECHNOLOGY AND BIOENGINEERING
- Effects of cell culture conditions on antibody N-linked glycosylation-what affects high mannose 5 glycoform
- (2011) Efren Pacis et al. BIOTECHNOLOGY AND BIOENGINEERING
- Optimizing amino acid composition of CHO cell culture media for a fusion protein production
- (2011) Zizhuo Xing et al. PROCESS BIOCHEMISTRY
- Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment
- (2010) Yao-Ming Huang et al. BIOTECHNOLOGY PROGRESS
- Role of iron and sodium citrate in animal protein-free CHO cell culture medium on cell growth and monoclonal antibody production
- (2010) Yunling Bai et al. BIOTECHNOLOGY PROGRESS
- Cell culture processes for monoclonal antibody production
- (2010) Feng Li et al. mAbs
- Identification of cell culture conditions to controlN-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells
- (2009) Martin Gawlitzek et al. BIOTECHNOLOGY AND BIOENGINEERING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now